Sun Gets Nod to Transfer Ranbaxy Investment

Published: 25th March 2015 06:04 AM  |   Last Updated: 25th March 2015 06:04 AM   |  A+A-

HYDERABAD: Nearly a year after announcing the acquisition of ailing Ranbaxy Laboratories Ltd, Sun Pharmaceuticals Industries, on Tuesday said the merger has finally been ‘consummated.’

The $4 billion deal was announced on April 7, 2014 and with Sun getting the Reserve Bank of India’s approval for transfer of  Ranbaxy’s overseas investments, approvals from respective High Courts and Registrar of Companies on Tuesday, all the statutory and regulatory compliances have been met.

Ranbaxy.jpg“With these filings, the merger of Ranbaxy into Sun Pharma has been consummated,” Sun said in a filing with the Bombay Stock Exchange.

The all-stock transaction including Ranbaxy’s $800 million debt component, has been the country’s biggest domestic acquisitions in the recent past. Following the merger, Sun emerged as the world’s fifth largest and the country’s largest drug firm by sales.

Currently, Ranbaxy is banned from importing its products from India plants to the US.

Earlier, Sun had indicated the acquisition to be accretive to earnings per share in the first full year and expects revenues of $250 million and operating synergies by the third year. According to Dilip Shanghvi,( the founder and MD of Sun Pharmaceuticals, the combined entity would focus on fixing manufacturing quality issues at Ranbaxy in order to resume exports.

Meanwhile, RBI’s approval involves transfer of overseas investments held by Ranbaxy in its joint venture and wholly-owned subsidiaries to Sun pursuant to the proposed merger.

It also approved issue of equity shares of Sun to the non-resident holders of equity shares of Ranbaxy.

More from Business


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp